Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Axsome Therapeutics, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
AXSM
Nasdaq
2834
www.axsome.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Axsome Therapeutics, Inc.
4 CNS Drug Stocks Worth Watching This World Mental Health Day
- Oct 9th, 2026 7:28 am
Axsome Therapeutics vs. Moderna: Which Biotech Stock Is a Better Buy in 2026?
- Oct 7th, 2026 8:29 pm
Axsome Therapeutics to Report Third Quarter 2026 Financial Results on November 2
- Oct 7th, 2026 5:00 am
Why Baird Sees Growth Potential in Axsome Therapeutics, Inc. (AXSM)
- Oct 5th, 2026 7:48 am
Axsome Therapeutics vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026?
- Oct 1st, 2026 1:17 pm
Jefferies Highlights Three Biotech Stocks With Blockbuster Potential
- Sep 30th, 2026 1:32 pm
Axsome Therapeutics Announces Results of the Shared Goals Survey of Caregivers of Patients with Alzheimer’s Disease Agitation Presented at Psych Congress 2026 in Connection with World Alzheimer’s Day
- Sep 21st, 2026 5:00 am
Axsome Sees AUVELITY Prescriptions Accelerate as Alzheimer’s Launch Gains Traction
- Sep 19th, 2026 12:02 pm
Axsome Therapeutics (AXSM) Stock Looks Undervalued As Its 5 Year 7x Run Continues
- Sep 19th, 2026 7:11 am
Is Axsome Therapeutics’ (AXSM) New CNS Data Enough To Reinforce Its Neuropsychiatric Portfolio Story?
- Sep 19th, 2026 5:14 am
Axsome Therapeutics Highlights Auvelity Growth, Pipeline Progress at H.C. Wainwright Conference
- Sep 19th, 2026 2:02 am
Axsome Therapeutics (AXSM) Reported New Clinical Data In Depression And Alzheimer’s Agitation
- Sep 18th, 2026 10:18 pm
Analysts Think Axsome Therapeutics Stock Could Soar 35% Over the Next 12 Months. Is the Stock a No-Brainer Buy?
- Sep 18th, 2026 4:22 pm
Axsome Therapeutics vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026?
- Sep 18th, 2026 1:25 pm
Axsome Therapeutics vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026?
- Sep 18th, 2026 7:00 am
Is Axsome Therapeutics a Buy on the Dip?
- Sep 18th, 2026 1:05 am
Axsome Therapeutics Presents Ten Posters Exemplifying its Innovative Psychiatry and Neurology Portfolio at Psych Congress 2026
- Sep 17th, 2026 5:00 am
AXSM Jumps 6% As Mizuho Calls Auvelity’s Alzheimer’s Launch A ‘Strong Start’
- Sep 11th, 2026 1:04 pm
Axsome Therapeutics vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
- Sep 11th, 2026 8:50 am
Axsome Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
- Sep 10th, 2026 11:30 am
Scroll